Helen M Boudreau

CIK 1661481 · Chief Financial Officer · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

26

Lifetime Open-Market Net

-$230.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
STTK Director $4.94 $0 7 2026-06-02
PINC Director 0 $50.16 $0 -$230.9K 9 2025-11-26
RLYB Director $15.92 $0 4 2025-05-15
Tvardi Therapeutics, Inc. (CARA) Delisted Director 150,647 $15.96 $2.40M $0 2 2024-06-06
KINETA, INC./DE (PTI) Delisted Chief Financial Officer $0 4 2018-03-05

Recent Filings · Page 2 of 3

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-05-16 PINC Sell (S) −6,629 -$131.6K EDGAR
2023-12-05 PINC Grant (A) +7,333 $0 EDGAR
2023-08-04 Tvardi Therapeutics, Inc. (CARA) Delisted Grant (A) $0 EDGAR
2023-05-31 STTK Grant (A) $0 EDGAR
2023-05-19 RLYB Grant (A) $0 EDGAR
2022-12-07 PINC Grant (A) +4,636 $0 EDGAR
2022-06-10 STTK Grant (A) $0 EDGAR
2022-05-26 RLYB Grant (A) $0 EDGAR
2021-12-07 PINC Grant (A) +4,098 $0 EDGAR
2021-06-22 STTK Grant (A) $0 EDGAR
Showing 1120 of 26
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.